Drug Pricing

Government Regulations Weight Loss Drugs Novo Nordisk Market Analysis Negotiation Market Competition Innovative Treatments Weight Loss Treatments Healthcare Costs Ozempic and Wegovy Discount Programs Market Comparison Market Access Middlemen Alzheimers Drugs Medicare Spending Government Regulation Weight-Loss Drugs Zepbound vs. Semaglutide Expensive Medicines Market Impact Weight Loss Drug Negotiations Generic Drugs

6 ARTICLES

3w ago

Johnson & Johnson Faces $400 Million in Tariff Costs as U.S.-China Trade Tensions Escalate

The company warns of potential additional costs from pharmaceutical tariffs under investigation by the Trump administration, while advocating for tax policy reforms to support U.S. manufacturing.

10 ARTICLES

3w ago

Merck Files Lawsuit Against Federal Government Over Medicare Drug Price Negotiations

Drug Pricing

Johnson & Johnson Faces $400 Million in Tariff Costs as U.S.-China Trade Tensions Escalate

Trump Signs Executive Order to Reform Medicare Drug Pricing and Lower Costs

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

Medicare to Cover Eli Lilly’s Zepbound for Sleep Apnea Treatment

Bernie Sanders and Elon Musk Unite on Lowering Ozempic Prices

FDA Approves Adaptimmune's Groundbreaking T-Cell Therapy for Rare Cancer

NHS England Secures Long-Term Access to Cystic Fibrosis Drugs

Novo Nordisk CEO to Testify on High U.S. Prices for Ozempic and Wegovy

FDA Approves Vertex/CRISPR Gene Therapy for Beta Thalassemia

Merck Files Lawsuit Against Federal Government Over Medicare Drug Price Negotiations